Literature DB >> 2867393

Serological evidence for virus related to simian T-lymphotropic retrovirus III in residents of west Africa.

F Barin, S M'Boup, F Denis, P Kanki, J S Allan, T H Lee, M Essex.   

Abstract

Serological evidence is presented here suggesting that a virus closely related to simian T-lymphotropic virus type III (STLV-III) infects man in Senegal, west Africa, a region where AIDS or AIDS-related diseases have not yet been observed. 25 sera from Senegalese individuals that were positive for antibodies to HTLV-III by enzyme-linked immunosorbent assay were examined for antibodies to HTLV-III and STLV-III by western blotting. Sera from individuals originating from regions where AIDS has been reported, such as the United States and Burundi (central Africa), reacted best with antigens of HTLV-III, although antibodies that cross-reacted with STLV-III p24 were also detected. Conversely, sera originating from Senegalese people reacted better with STLV-III than with HTLV-III. This was exemplified by the absence of reactivity in sera from both monkeys and Senegalese people to p41, an antigen regularly detected by sera from antibody positive individuals originating from central Africa or from the United States. In contrast sera from central Africa or the United States did not react with p32, the putative envelope transmembrane protein of STLV-III that is regularly detected by sera from both monkeys and antibody-positive Senegalese people. These results suggest that certain healthy Senegalese people have been exposed to a virus that is more closely related to STLV-III than to HTLV-III. The existence and study of such virus variants potentially with differential pathogenicity may provide important information for the development of an AIDS virus vaccine.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2867393     DOI: 10.1016/s0140-6736(85)92556-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  40 in total

1.  Human immunodeficiency virus type 2 envelope glycoprotein binds to CD8 as well as to CD4 molecules on human T cells.

Authors:  H Kaneko; L P Neoh; N Takeda; H Akimoto; T Hishikawa; H Hashimoto; S Hirose; S Karaki; M Takiguchi; H Nakauchi; Y Kaneko; N Yamamoto; I Sekigawa
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  AIDS in primates.

Authors:  A J Zuckerman
Journal:  Br Med J (Clin Res Ed)       Date:  1986-01-18

3.  Seroepidemiology of human immunodeficiency virus in Africa.

Authors:  I Wendler; J Schneider; B Gras; A F Fleming; G Hunsmann; H Schmitz
Journal:  Br Med J (Clin Res Ed)       Date:  1986-09-27

4.  Envelope cross-reactivity between human immunodeficiency virus types 1 and 2 detected by different serological methods: correlation between cross-neutralization and reactivity against the main neutralizing site.

Authors:  B Böttiger; A Karlsson; P A Andreasson; A Nauclér; C M Costa; E Norrby; G Biberfeld
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

5.  Epidemiological correlations between African AIDS and AIDS in Europe.

Authors:  N Clumeck
Journal:  Infection       Date:  1986 May-Jun       Impact factor: 3.553

6.  Salivary antibodies as a means of detecting human T cell lymphotropic virus type III/lymphadenopathy-associated virus infection.

Authors:  D W Archibald; L I Zon; J E Groopman; J S Allan; M F McLane; M E Essex
Journal:  J Clin Microbiol       Date:  1986-11       Impact factor: 5.948

7.  AIDS and Africa: lessons for us all.

Authors:  A J Pinching
Journal:  J R Soc Med       Date:  1986-09       Impact factor: 5.344

8.  Isolation of a novel simian T-cell lymphotropic virus from Pan paniscus that is distantly related to the human T-cell leukemia/lymphotropic virus types I and II.

Authors:  A Giri; P Markham; L Digilio; G Hurteau; R C Gallo; G Franchini
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

9.  Genomic cloning and complete sequence analysis of a highly divergent African human immunodeficiency virus isolate.

Authors:  M Vanden Haesevelde; J L Decourt; R J De Leys; B Vanderborght; G van der Groen; H van Heuverswijn; E Saman
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

10.  Molecular mimicry between the human immunodeficiency virus type 1 gp120 V3 loop and human brain proteins.

Authors:  J R Trujillo; M F McLane; T H Lee; M Essex
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.